Accessibility
EasyRead Text Version
Showing 1 to 7 of 7 Results
Aman M. G. et al. (2010)
Line-item analysis of the Aberrant Behavior Checklist: results from two studies of aripiprazole in the treatment of irritability associated with autistic disorder.
Journal of Child and Adolescent Psychopharmacology
20(5), pp. 415-422.
Read Abstract (New Window)
Findling R. L. et al. (2014)
A randomized controlled trial investigating the safety and efficacy of aripiprazole in the long-term maintenance treatment of pediatric patients with irritability associated with autistic disorder.
Journal of Clinical Psychiatry
75(1), pp. 22-30,
Mankoski R. et al. (2013)
Aripiprazole treatment of irritability associated with autistic disorder and the relationship between prior antipsychotic exposure, adverse events, and weight change.
23(8), pp. 572-576.
Marcus R. N. et al. (2011)
Aripiprazole in the treatment of irritability in pediatric patients (aged 6-17 years) with autistic disorder: results from a 52-week, open-label study.
21(3), pp. 229-236
Safety and tolerability of aripiprazole for irritability in pediatric patients with autistic disorder: a 52-week, open-label, multicenter study.
72(9), pp. 1270-1276.
Robb A. S. et al. (2011)
Safety and tolerability of aripiprazole in the treatment of irritability associated with autistic disorder in pediatric subjects (6-17 years old):results from a pooled analysis of 2 studies.
Primary Care Companion to CNS Disorders
13(1), pii: PCC.10m01008
Read Abstract (New Window) Read Full (New Window)
Varni J. W. et al. (2012)
Effect of aripiprazole 2 to 15 mg/d on health-related quality of life in the treatment of irritability associated with autistic disorder in children: A post hoc analysis of two controlled trials.
Clinical Therapeutics
34(4), pp. 980-992.
Publications | Publications Database | Search Publications
Rate This Page
Poor | Satisfactory | Good | Excellent
Print This Page / view All
Back to top
Your Rating:
